Issa Khouri
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Issa Khouri as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01919619 · Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid MalignanciesM.D. Anderson Cancer Center · completed · B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Leukemia · principal investigator
- Ph1/Ph2NCT01664910 · CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid MalignanciesM.D. Anderson Cancer Center · completed · Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
- Ph1NCT00880815 · Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell TransplantM.D. Anderson Cancer Center · completed · CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma · principal investigator
- Ph2NCT00439556 · Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell TransplantM.D. Anderson Cancer Center · completed · CD20 Positive, Hematopoietic and Lymphoid Cell Neoplasm, Lymphocytic Neoplasm · principal investigator
- Ph1/Ph2NCT00002838 · Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic LeukemiaM.D. Anderson Cancer Center · completed · Leukemia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Experimental Medicine ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2013 to 2026
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:40 UTC. The ranking covers the 200 most relevant of 89 PubMed records, and a shared surname and initials can bring in a namesake. All 89 on PubMed
- 937 citationsRCR 23.9
- 509 citationsRCR 12.5
- 278 citationsRCR 6.2
- 241 citationsRCR 5.6
- 204 citationsRCR 4.6
- Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.Biol Blood Marrow Transplant · 2012203 citationsRCR 6.1
- Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.Bone Marrow Transplant · 2008188 citationsRCR 4.5
- Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.Biol Blood Marrow Transplant · 2014183 citationsRCR 6.1
- Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.J Clin Oncol · 1994180 citationsRCR 5.8
- 172 citationsRCR 4.2